CoChat

T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma

Barsch, Maryam, Salié, Henrike, Schlaak, Alexandra Emilia, Zhang, Zhen, Hess, Moritz, Mayer, Lena Sophie, Tauber, Catrin, Otto-Mora, Patricia, Ohtani, Takuya, Nilsson, Tobias, Wischer, Lara, Winkler, Frances, Manne, Sasikant, Rech, Andrew, Schmitt-Graeff, Annette, Bronsert, Peter, Hofmann, Maike, Neumann-Haefelin, Christoph, Boettler, Tobias, Fichtner-Feigl, Stefan, van Boemmel, Florian, Berg, Thomas, Rimassa, Lorenza, Di Tommaso, Luca, Saeed, Anwaar, D’Alessio, Antonio, Pinato, David J., Bettinger, Dominik, Binder, Harald, John Wherry, E., Schultheiss, Michael, Thimme, Robert, Bengsch, Bertram · 2022 · Journal of Hepatology
Cited by 186

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND AIMS Despite recent translation of immunotherapies into clinical practice, the immunobiology of hepatocellular carcinoma, in particular the role and clinical relevance of exhausted and liver-resident T cells remain unclear. We therefore dissected the landscape of exhausted and resident T cell responses in the peripheral blood and tumor microenvironment of HCC patients. METHODS Lymphocytes were isolated from blood, tumor and tumor-surrounding liver tissue from HCC patients (n=40, n=10 treated with anti-PD-1 therapy). Phenotype, function and response to anti-PD-1 were analyzed by mass and flow cytometry ex vivo and in vitro, tissue residence was further assessed by immunohistochemistry and imaging mass cytometry. Gene signatures were assessed in silico. RESULTS We identified significant enrichment of heterogeneous populations of exhausted CD8+ T cells (TEX) in the tumor microenvironment. Strong enrichment of severely exhausted CD8 T cells expressing multiple immune checkpoints in addition to PD-1 was linked to poor progression-free and overall survival. In contrast, PD-1 was also expressed on a subset of more functional and metabolically active CD103+ tissue-resident memory T cells (TRM) that expressed few additional immune checkpoints and were associated with better survival. TEX enrichment was independent from BCLC stage, AFP levels or age as a variable for progression-free survival in our cohort. These findings were in line with in silico gene signature analysis of TCGA-HCC tumor transcriptomes. A higher baseline TEX/TRM ratio was associated with disease control in anti-PD-1 treated patients. CONCLUSION Our data inform about a role of peripheral and intratumoral TEX - TRM dynamics in determining the outcomes of HCC patients. The dynamics between exhausted and liver-resident T cells have implications for immune-based diagnostics, rational patient selection and monitoring during HCC immunotherapies. LAY SUMMARY The role of the immune response in hepatocellular carcinoma (HCC) remains unclear. T cells, particularly effector or tissue-resident T cells can mediate protection against tumor cells, but are frequently dysfunctional and exhausted in cancer. To understand if these immune populations play significant roles in HCC, we investigated blood and tumor-derived T cells from HCC patients for different T cell types using advanced immune profiling technology able to characterize these populations in detail. We found that patients with a dominance of exhausted CD8+ T cells (TEX) had poor survival, in contrast to patients with a dominance of tissue-resident memory cells (TRM) and longer survival. This correlated with the molecular profile, metabolic and functional status of these cell populations. The enrichment of TEX was independently associated with prognosis in addition to disease stage, age and tumor markers. A high TRM proportion was also associated with better outcome to checkpoint therapy. Thus, these T cell populations are novel biomarkers relevant for HCC patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2022.02.032

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

Metadata

Authors
Barsch, M., Salié, H., Schlaak, A. E., Zhang, Z., Hess, M., Mayer, L. S., Tauber, C., Otto-Mora, P., Ohtani, T., Nilsson, T., Wischer, L., Winkler, F., Manne, S., Rech, A., Schmitt-Graeff, A., Bronsert, P., Hofmann, M., Neumann-Haefelin, C., Boettler, T., Fichtner-Feigl, S., van Boemmel, F., Berg, T., Rimassa, L., Di Tommaso, L., Saeed, A., D’Alessio, A., Pinato, D. J., Bettinger, D., Binder, H., John Wherry, E., Schultheiss, M., Thimme, R., & Bengsch, B.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2022-08
Volume
77
Issue
2
Pages
397-409
ISSN
0168-8278 (ISSN-L)
OpenAlex
W4221039330
Cited by
186
References
14
FWCI
15.23
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.